| IRONWOOD PHARMA.A DL-,001 |
| USA |
| Gesundheit |
| US46333X1081 / A0X789 |
| I76 (Frankfurt) / IRWD (NASDAQ) |
| FRA:I76, ETR:I76, I76:GR, NASDAQ:IRWD |
| - |
| http://www.ironwoodpharma.. |
|
Ironwood Pharmaceuticals, Inc. Class A Common Stock represents ownership in Ironwood Pharmaceuticals, Inc., a biotechnology company focused on developing and commercializing therapies for gastrointestinal disorders and rare diseases. Its current busi..
>Volltext.. |
| 535.78 Mio. EUR |
| 813.03 Mio. EUR |
| 345.84 Mio. EUR |
| 211.34 Mio. EUR |
| 115.37 Mio. EUR |
| 0.71 EUR |
| 352.55 Mio. EUR |
| 70.29 Mio. EUR |
| 164.83 Mio. EUR |
| 2.41 |
| 30.16% |
| - |
| - |
| - |
| - |
| - |
| IRONWOOD |
| 07.10.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|